XML 69 R54.htm IDEA: XBRL DOCUMENT
v3.22.2

Non-controlling interests (Tables) | 12 Months Ended
--- | ---
May 31, 2022
Text Block [Abstract] |
Summary of Information Relating to Company's Majority Owned Subsidiaries | The following tables summarize the information relating to the Company’s majority-owned subsidiaries, CC Pharma Nordic ApS (75%), Aphria Diamond (51%), ColCanna S.A.S. (90%), and SH Acquisition (68%) before intercompany eliminations. Summarized balance sheet information of the entities in which there is a non-controlling interest as at May 31, 2022:
|  | CC Pharma |  |  | Aphria |  |  | SH |  |  | ColCanna |  |  |  |  |
|  | Nordic ApS |  |  | Diamond |  |  | Acquisition |  |  | S.A.S. |  |  | Total |
Current assets |  | $ | 485 |  |  | $ | 20,546 |  |  | $ | — |  |  | $ | 193 |  |  | $ | 21,224 |
Non-current assets |  |  | 158 |  |  |  | 152,786 |  |  |  | 111,200 |  |  |  | 141,929 |  |  |  | 406,073 |
Current liabilities |  |  | (642 | ) |  |  | (63,196 | ) |  |  | — |  |  |  | (53 | ) |  |  | (63,891 | )
Non-current liabilities |  |  | (410 | ) |  |  | (29,653 | ) |  |  | — |  |  |  | (6,537 | ) |  |  | (36,600 | )
Net assets |  |  | (409 | ) |  |  | 80,483 |  |  |  | 111,200 |  |  |  | 135,532 |  |  |  | 326,806 |
Summarized balance sheet information of the entities in which there is a non-controlling interest as at May 31, 2021:
|  | CC Pharma |  |  | Aphria |  |  | SH |  |  | ColCanna |  |  |  |  |
|  | Nordic ApS |  |  | Diamond |  |  | Acquisition |  |  | S.A.S. |  |  | Total |
Current assets |  | $ | 919 |  |  | $ | 19,531 |  |  | $ | — |  |  | $ | 315 |  |  | $ | 20,765 |
Non-current assets |  |  | 103 |  |  |  | 153,696 |  |  |  | — |  |  |  | 146,587 |  |  |  | 300,386 |
Current liabilities |  |  | (956 | ) |  |  | (28,511 | ) |  |  | — |  |  |  | (62 | ) |  |  | (29,529 | )
Non-current liabilities |  |  | (406 | ) |  |  | (69,332 | ) |  |  | — |  |  |  | (6,606 | ) |  |  | (76,344 | )
Net assets |  |  | (340 | ) |  |  | 75,384 |  |  |  | — |  |  |  | 140,234 |  |  |  | 215,278 |
Summarized income statement information of the entities in which there is a non-controlling interest for the year ended May 31, 2022:
|  | CC Pharma |  |  | Aphria |  |  | SH |  |  | ColCanna |  |  |  |  |
|  | Nordic ApS |  |  | Diamond |  |  | Acquisition |  |  | S.A.S. |  |  | Total |
Revenue |  | $ | 354 |  |  | $ | 148,323 |  |  | $ | — |  |  | $ | — |  |  | $ | 148,677 |
Total expenses (recovery) |  |  | 470 |  |  |  | 77,057 |  |  |  | (11,180 | ) |  |  | 35 |  |  |  | 66,382 |
Net (loss) income |  |  | (116 | ) |  |  | 71,266 |  |  |  | 11,180 |  |  |  | (35 | ) |  |  | 82,295 |
Other comprehensive (loss) income |  |  | 47 |  |  |  | (2,353 | ) |  |  | (70,778 | ) |  |  | (4,737 | ) |  | $ | (77,821 | )
Net comprehensive income |  |  | (69 | ) |  |  | 68,913 |  |  |  | (59,598 | ) |  |  | (4,772 | ) |  |  | 4,474 |
Summarized income statement information of the entities in which there is a non-controlling interest for the year ended May 31, 2021:
|  | CC Pharma |  |  | Aphria |  |  | ColCanna |  |  |  |  |
|  | Nordic ApS |  |  | Diamond |  |  | S.A.S. |  |  | Total |
Revenue |  | $ | 827 |  |  | $ | 131,381 |  |  | $ | — |  |  | $ | 132,208 |
Total expenses (recovery) |  |  | 958 |  |  |  | 67,030 |  |  |  | 923 |  |  |  | 68,911 |
Net (loss) income |  |  | (131 | ) |  |  | 64,351 |  |  |  | (923 | ) |  |  | 63,297 |
Other comprehensive (loss) income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Net comprehensive loss |  |  | (131 | ) |  |  | 64,351 |  |  |  | (923 | ) |  |  | 63,297 |
Summarized income statement information of the entities in which there is a non-controlling interest for the year ended May 31, 2020:
|  | Aphria Diamond |  |  | Marigold |  |  | ColCanna S.A.S. |  |  | Total |
Revenue |  | $ | 24,142 |  |  | $ | 40 |  |  | $ | — |  |  | $ | 24,182 |
Total expenses (recovery) |  |  | 25,141 |  |  |  | (4,995 | ) |  |  | (19,447 | ) |  |  | 699 |
Net (loss) income |  |  | (999 | ) |  |  | 5,035 |  |  |  | 19,447 |  |  |  | 23,483 |
Other comprehensive (loss) income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Net comprehensive loss |  |  | (999 | ) |  |  | 5,035 |  |  |  | 19,447 |  |  |  | 23,483 |

X
- Definition The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4M -URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686 + Details
Name: | us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration